age |
|
1240 (93.0) |
93 (7.0) |
0.98 (0.96–1.00) |
0.09 |
0.99
(0.96–1.01) |
0.20 |
antihypertensive treatment with β-blockers or ACEI |
no |
920 (92.6) |
74 (7.4) |
1.00 |
0.25 |
1.00 |
0.61 |
|
yes |
319 (94.4) |
19 (5.6) |
0.74 (0.43–1.22) |
|
0.87 (0.49–1.52) |
|
cardiovascular disease |
no |
734 (92.1) |
63 (7.9) |
1.00 |
0.11 |
.. |
.. |
|
yes |
498 (94.3) |
30 (5.7) |
0.69 (0.43–1.08) |
|
.. |
|
bee venom |
no |
879 (95.8) |
39 (4.3) |
1.00 |
<0.001 |
1.00 |
<0.001 |
|
yes |
360 (87.0) |
54 (13.0) |
3.39 (2.20–5.27) |
|
3.35 (2.17–5.16) |
|
tryptase* |
≤ 11.4µg/L |
1010 (93.2) |
74 (6.8) |
1.00 |
0.16 |
.. |
.. |
|
> 11.4µg/L |
107 (89.2) |
13 (10.8) |
1.54 (0.83–2.90) |
|
.. |
|
verified mastocytosis* |
no |
1,144 (93.1) |
85 (6.9) |
1.00 |
0.41 |
.. |
.. |
|
yes |
29 (87.9) |
4 (12.1) |
1.71 (0.57–5.14) |
|
.. |
|
sIgE levels (bee venom) |
>0.35–3.5 kU/l |
96 (85.0) |
17
(15.0) |
1.00 |
0.99 |
.. |
.. |
|
>3.5–17.5 kU/l |
97 (85.1) |
17 (14.9) |
0.97
(0.46–2.06) |
|
.. |
|
|
>17.5 kU/l |
45 (84.9) |
8 (15.1) |
0.92 (0.34–2.31) |
|
.. |
|
sIgE levels (vespid venom) |
>0.35–3.5 kU/l |
270 (94.1) |
17 (5.9) |
1.00 |
0.15 |
.. |
.. |
|
>3.5–17.5 kU/l |
281 (96.9) |
9 (3.1) |
0.52
(0.22–1.17) |
|
.. |
|
|
>17.5 kU/l |
148 (97.4) |
4 (2.6) |
0.42 (0.12–1.17) |
|
.. |
|
Grading Ring-Messmer (initial sting reaction) |
1&2 |
714 (93.3) |
51
(6.7) |
1.00 |
0.66 |
.. |
.. |
|
3&4 |
526 (92.6) |
42 (7.4) |
1.10 (0.72–1.69) |
|
.. |
|
Premedication with H1-antihistamine |
no |
606 (94.3) |
37 (5.8) |
1.00 |
0.07 |
.. |
.. |
|
yes |
634 (91.9) |
56 (8.1) |
1.67 (0.96–3.18) |
|
.. |
|
up-dosing protocol |
conventional |
104 (95.4) |
5 (4.6) |
1.00 |
0.50 |
.. |
.. |
|
rush, cluster, ultrarush |
1128 (93.1) |
84 (6.9) |
1.40 (0.54–4.23) |
|
.. |
|